Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults
Neuro-Oncology · 06.07.2023 · 25 (7) · 1200-1224
DOI: 10.1093/neuonc/noad038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 27.02.2023. Verfasst von Michael Weller und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Brain Neoplasms, Central Nervous System Neoplasms, Lymphoma. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Central nervous system (CNS) tumor patients commonly undergo multimodality treatment in the course of their disease. Adverse effects and complications from these interventions have not been systematically studied, but pose significant challenges in clinical practice and impact function and quality of life, especially in the management of long-term brain tumor survivors. Here, the European Association of Neuro-Oncology (EANO) has developed recommendations to prevent, diagnose, and manage adverse effects and complications in the adult primary brain CNS tumor (except lymphomas) patient population with a specific focus on surgery, radiotherapy, and pharmacotherapy. Specifically, we also provide recommendations for dose adaptations, interruptions, and reexposure for pharmacotherapy that may serve as a reference for the management of standard of care in clinical trials. We also summarize which interventions are unnecessary, inactive or contraindicated. This consensus paper should serve as a reference for the conduct of standard therapy within and outside of clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.
- Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
- The Brain Tumour Center at the Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
- Department of Neurological Surgery, University of California, San Francisco, California, USA.
- Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
- Center of Neurosurgery, Department of General Neurosurgery, University of Cologne, Cologne, Germany.
ORCID-Profile: Michael Weller, Motoo Nagane, Ghazaleh Tabatabai, Matthias Preusser
Förderung
- NCI NIH HHS
Zitieren
APA
Weller, M., Le Rhun, E., Van den Bent, M., Chang, S. M., Cloughesy, T. F., Goldbrunner, R., Hong, Y. K., Jalali, R., Jenkinson, M. D., Minniti, G., Nagane, M., Razis, E., Roth, P., Rudà, R., Tabatabai, G., Wen, P. Y., Short, S. C., & Preusser, M. (2023). Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults. Neuro-Oncology, 25(7), 1200-1224. https://doi.org/10.1093/neuonc/noad038
Vancouver
Weller M, Le Rhun E, Van den Bent M, Chang SM, Cloughesy TF, Goldbrunner R, et al. Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults. Neuro-Oncology. 2023;25(7):1200-1224. doi:10.1093/neuonc/noad038
BibTeX
@article{Weller2023,
author = {Weller, Michael and Le Rhun, Emilie and Van den Bent, Martin and Chang, Susan M and Cloughesy, Timothy F and Goldbrunner, Roland and Hong, Yong-Kil and Jalali, Rakesh and Jenkinson, Michael D and Minniti, Giuseppe and Nagane, Motoo and Razis, Evangelia and Roth, Patrick and Rudà, Roberta and Tabatabai, Ghazaleh and Wen, Patrick Y and Short, Susan C and Preusser, Matthias},
title = {Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults},
journal = {Neuro-Oncology},
year = {2023},
volume = {25},
number = {7},
pages = {1200--1224},
doi = {10.1093/neuonc/noad038}
}
EUVIMED